IL115754A - Liposomic composition containing selegilin and process for its preparation - Google Patents

Liposomic composition containing selegilin and process for its preparation

Info

Publication number
IL115754A
IL115754A IL11575495A IL11575495A IL115754A IL 115754 A IL115754 A IL 115754A IL 11575495 A IL11575495 A IL 11575495A IL 11575495 A IL11575495 A IL 11575495A IL 115754 A IL115754 A IL 115754A
Authority
IL
Israel
Prior art keywords
weight
liposomic
pct
selegilin
composition
Prior art date
Application number
IL11575495A
Other languages
English (en)
Other versions
IL115754A0 (en
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of IL115754A0 publication Critical patent/IL115754A0/xx
Publication of IL115754A publication Critical patent/IL115754A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Detergent Compositions (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL11575495A 1994-10-24 1995-10-24 Liposomic composition containing selegilin and process for its preparation IL115754A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9403073A HU223475B1 (hu) 1994-10-24 1994-10-24 Selegilint tartalmazó liposzoma-készítmény és eljárás ennek előállítására

Publications (2)

Publication Number Publication Date
IL115754A0 IL115754A0 (en) 1996-01-19
IL115754A true IL115754A (en) 1999-07-14

Family

ID=10985697

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11575495A IL115754A (en) 1994-10-24 1995-10-24 Liposomic composition containing selegilin and process for its preparation

Country Status (30)

Country Link
US (1) US5888536A (sk)
EP (1) EP0788349B1 (sk)
JP (1) JPH10507749A (sk)
KR (1) KR100313149B1 (sk)
CN (1) CN1084186C (sk)
AT (1) ATE205387T1 (sk)
AU (1) AU691348B2 (sk)
BG (1) BG63327B1 (sk)
BR (1) BR9509517A (sk)
CA (1) CA2203513C (sk)
CZ (1) CZ287349B6 (sk)
DE (1) DE69522701T2 (sk)
DK (1) DK0788349T3 (sk)
EE (1) EE03418B1 (sk)
ES (1) ES2160718T3 (sk)
FI (1) FI971743A (sk)
HU (1) HU223475B1 (sk)
IL (1) IL115754A (sk)
NO (1) NO316354B1 (sk)
NZ (1) NZ294660A (sk)
PL (1) PL183104B1 (sk)
PT (1) PT788349E (sk)
RO (1) RO116768B1 (sk)
RU (1) RU2159106C2 (sk)
SK (1) SK281599B6 (sk)
TW (1) TW412420B (sk)
UA (1) UA44289C2 (sk)
WO (1) WO1996012472A1 (sk)
YU (1) YU49313B (sk)
ZA (1) ZA958999B (sk)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2472499A (en) * 1998-01-27 1999-08-09 Thomas N. Thomas Methods of treatment using mao-a and mao-b inhibitors such as l-deprenyl
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
CA2536393A1 (en) * 2003-09-09 2005-06-16 Gilead Sciences, Inc. Use of liposomes which are small unilamellar vesicles for the removal of an entity from a biological sample
EP1848541A4 (en) * 2005-02-07 2013-01-16 Pharmalight Inc METHOD AND DEVICE FOR OPHTHALMIC DELIVERY OF PHARMACEUTICALLY ACTIVE INGREDIENTS
CN1813679A (zh) * 2005-11-30 2006-08-09 上海医药(集团)有限公司 一种紫杉烷脂质体冻干组合物及其制备方法
US9445975B2 (en) * 2008-10-03 2016-09-20 Access Business Group International, Llc Composition and method for preparing stable unilamellar liposomal suspension
JP5623102B2 (ja) * 2010-03-12 2014-11-12 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
JP5693026B2 (ja) * 2010-03-12 2015-04-01 株式会社フジモト・コーポレーション セレギリン含有貼付製剤
RU2678433C2 (ru) 2012-05-10 2019-01-29 Пейнреформ Лтд. Депо-составы гидрофобного активного ингредиента и способы их получения
AU2015326378B2 (en) * 2014-09-29 2021-01-21 Council Of Scientific & Industrial Research A formulation useful for delivery of neuro protecting agent
EP3600435B1 (en) * 2017-03-23 2024-03-20 Lipid Systems sp. z.o.o. High-efficiency encapsulation of hydrophilic compounds in unilamellar liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH588887A5 (sk) * 1974-07-19 1977-06-15 Battelle Memorial Institute
US4485054A (en) * 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4761288A (en) * 1984-09-24 1988-08-02 Mezei Associates Limited Multiphase liposomal drug delivery system
GB8807504D0 (en) * 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4937078A (en) * 1988-08-26 1990-06-26 Mezei Associates Limited Liposomal local anesthetic and analgesic products
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.

Also Published As

Publication number Publication date
EE03418B1 (et) 2001-06-15
ZA958999B (en) 1996-05-15
PL183104B1 (pl) 2002-05-31
CZ287349B6 (en) 2000-10-11
CZ114797A3 (en) 1997-10-15
PT788349E (pt) 2001-12-28
HUT76053A (en) 1997-06-30
WO1996012472A1 (en) 1996-05-02
FI971743A0 (fi) 1997-04-23
EP0788349A1 (en) 1997-08-13
FI971743A (fi) 1997-04-23
YU67195A (sh) 1998-07-10
KR970706797A (ko) 1997-12-01
RU2159106C2 (ru) 2000-11-20
NO971870D0 (no) 1997-04-23
TW412420B (en) 2000-11-21
SK51797A3 (en) 1997-11-05
CN1163563A (zh) 1997-10-29
YU49313B (sh) 2005-06-10
EE9700102A (et) 1997-10-15
UA44289C2 (uk) 2002-02-15
SK281599B6 (sk) 2001-05-10
DE69522701D1 (de) 2001-10-18
NZ294660A (en) 1998-05-27
DK0788349T3 (da) 2001-11-26
AU3751895A (en) 1996-05-15
KR100313149B1 (ko) 2002-02-19
BR9509517A (pt) 1997-12-30
US5888536A (en) 1999-03-30
EP0788349B1 (en) 2001-09-12
PL319875A1 (en) 1997-09-01
AU691348B2 (en) 1998-05-14
BG63327B1 (bg) 2001-10-31
CN1084186C (zh) 2002-05-08
DE69522701T2 (de) 2002-07-11
NO316354B1 (no) 2004-01-19
MX9703019A (es) 1997-10-31
HU9403073D0 (en) 1994-12-28
CA2203513C (en) 2001-10-09
NO971870L (no) 1997-06-24
JPH10507749A (ja) 1998-07-28
IL115754A0 (en) 1996-01-19
ES2160718T3 (es) 2001-11-16
ATE205387T1 (de) 2001-09-15
RO116768B1 (ro) 2001-06-29
HU223475B1 (hu) 2004-07-28
CA2203513A1 (en) 1996-05-02
BG101432A (en) 1997-12-30

Similar Documents

Publication Publication Date Title
GR3036772T3 (en) Topically applied pharmaceutical composition, method of preparing it and its use
JP2002003364A (ja) 点眼剤、眼科用組成物及び吸着抑制方法
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
IL115754A (en) Liposomic composition containing selegilin and process for its preparation
JP3142842B1 (ja) 眼科用組成物及びソフトコンタクトレンズへの吸着抑制方法
JP2023090938A (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用点眼剤
JP3175742B1 (ja) コンタクトレンズ用眼科用組成物
JP3734521B2 (ja) 点眼製剤
JP2001253822A (ja) 角膜細胞回復剤組成物
TW200733897A (en) Oral product for moistening skin
JP5650864B2 (ja) 非イオン性シリコーンハイドロゲルコンタクトレンズ用眼科組成物
JP2002104971A (ja) 眼科用組成物
JP2005075735A (ja) オキシメタゾリン含有組成物
JP2024006961A (ja) オートファジー活性化剤及びオートファジー活性低下抑制方法
JP2001187741A (ja) 皮膚外用医薬組成物
JPH11180872A (ja) 骨代謝改善剤

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees